HR21-00046
|
Decoding the paracrine control of metabolic fitness by endothelial nutrient signaling
|
Alejo Efeyan
|
Fundación del Sector Público Estatal Centro Nacional de Investigaciones Oncológicas Carlos III
|
Institut d'Investigació Biomèdica de Bellvitge (IDIBELL) - Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS)
|
Cardiovascular and associated metabolic diseases
|
Research Consortium
|
992.580,60
|
HR21-00386
|
High precision cardioprotective therapy: a photoswitchable approach to reduce the extension of myocardial infarction
|
Amadeu Llebaria
|
Consejo Superior de Investigaciones Científicas (CSIC)
|
Fundació Hospital Universitari Vall d'Hebron - Institut de Recerca (VHIR) - Purdue University, West Lafayette, IN - GICOR
|
Cardiovascular and associated metabolic diseases
|
Research Consortium
|
999.779,50
|
HR21-00430
|
Phospholipid biosynthesis and transport between endoplasmic reticulum and mitochondria: understanding their essential role in liver disorders
|
Antonio Zorzano
|
Fundació Institut de Recerca Biomèdica (IRB Barcelona)
|
Universitat de Barcelona - Fundació Institut d'Investigació Sanitària Pere Virgili
|
Cardiovascular and associated metabolic diseases
|
Research Consortium
|
997.014
|
HR21-00233
|
Loss of Triadin impairs cardiac proteostasis disclosing pathophysiological complexity in Catecholaminergic Polymorphic Ventricular Tachycardia Type 5
|
Silvia Giuliana Priori
|
Fundación Centro Nacional de Investigaciones Cardiovasculares Carlos III - CNIC
|
N/A
|
Cardiovascular and associated metabolic diseases
|
Individual
|
496.100
|
HR21-00793
|
RIPK3 biology and targeting in metabolic liver disease
|
Cecilia Rodrigues
|
FARM-ID - Associação da Faculdade de Farmácia para a Investigação e Desenvolvimento
|
N/A
|
Cardiovascular and associated metabolic diseases
|
Individual
|
320.000,07
|
HR21-00375
|
Massively parallel mutagenesis to understand, predict and prevent amyloid nucleation in neurodegenerative diseases
|
Ben Lehner
|
Centre de Regulació Genòmica (CRG)
|
Institut de Bioenginyeria de Catalunya
|
Enabling technologies
|
Research Consortium
|
994.048,90
|
HR21-00925
|
Development of enabling technologies for T-cell immunotherapy of solid tumors
|
Sonia Guedan
|
Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS)
|
Asociación Centro de Investigación Cooperativa en Biociencias (CIC bioGUNE) - Fundació privada Institut Investigació Oncologica Vall Hebron (VHIO)
|
Enabling technologies
|
Research Consortium
|
963.488
|
HR21-00410
|
Graphene aptasensor bioelectronics: a neural interface for neurotransmission probing in neurological disorders
|
Pedro Alpuim
|
Laboratorio Iberico Internacional de Nanotecnologia
|
Universidade do Minho - Consejo Superior de Investigaciones Científicas (CSIC)
|
Enabling technologies
|
Research Consortium
|
997.692,19
|
HR21-00208
|
Enzyme propelled nanobots as efficient nanotech platform for bladder cancer therapy
|
Samuel Sánchez
|
Institut de Bioenginyeria de Catalunya
|
Asociación Centro de Investigación Cooperativa en Biomateriales - Universitat Autònoma de Barcelona (UAB) - Fundació Clínic per a la Recerca Biomèdica -Fundacio Catalunya-La Pedrera Fundacio Especial - Universitat de Barcelona - Fundació Bosch i Gimpera
|
Enabling Technologies
|
Research Consortium
|
997.946,50
|
HR21-00415
|
A multidisciplinary approach to understand host and pathogen interactions to develop new strategies to target tuberculosis
|
Margarida Saraiva
|
i3S – Instituto de Investigação e Inovação em Saúde da Universidade do Porto - Associação
|
Consejo Superior de Investigaciones Científicas (CSIC) - Francis Crick Institute
|
Infectious diseases
|
Research Consortium
|
998.404
|
HR21-00848
|
Whole-organism vaccines against P. falciparum and P. vivax malaria with enhanced efficacy and scope
|
Miguel Prudêncio
|
Instituto de Medicina Molecular
|
Leiden University Medical Centre - US Naval Medical Research Unit 6
|
Infectious diseases
|
Research Consortium
|
997.453,50
|
HR21-01020
|
Neuron-astrocyte signaling in depression: learning from astrocytes how to effectively treat depression
|
João Filipe Oliveira
|
Universidade do Minho
|
N/A
|
Neuroscience
|
Individual
|
499.478,45
|
HR21-00171
|
Novel organ-on-a-chip technology to study extracellular vesicles-mediated cryptic infections in Plasmodium vivax malaria
|
Hernando A. del Portillo
|
Institut de Salut Global de Barcelona (ISGlobal)
|
i3S – Instituto de Investigação e Inovação em Saúde da Universidade do Porto - Associação - Universitat de Barcelona - Mahidol University
|
Infectious diseases
|
Research Consortium
|
996.930,57
|
HR21-00368
|
Molecular dissection of TNF-mediated pathogenic macrophage necrosis in tuberculosis
|
Francisco Jose Roca
|
Universidad de Murcia
|
N/A
|
Infectious diseases
|
Individual
|
460.252,80
|
HR21-00737
|
Acquisition of antifungal resistance in pathogenic Candida spp.: evolutionary paths, fitness trade-offs, and interplay with the immune system
|
Toni Gabaldón
|
Fundació Institut de Recerca Biomèdica (IRB Barcelona)
|
N/A
|
Infectious diseases
|
Individual
|
499.244
|
HR21-00622
|
In vivo reprogramming to rescue alterations in Huntington’s disease
|
Josep M. Canals
|
Universitat de Barcelona - Fundació Bosch i Gimpera
|
Lund University - Cardiff University - Institute of Molecular Biotechnology (IMBA)- European Huntington's Disease Network
|
Neuroscience
|
Research Consortium
|
994.890
|
HR21-00259
|
From GFAP mutations in astrocytes to neurodegeneration: exploring a lipid-protein oxidation pathway
|
Dolores Pérez-Sala
|
Consejo Superior de Investigaciones Científicas (CSIC)
|
Brain Center, University Medical Center Utrecht -University of Copenhagen - University of Gothenburg -Institut De Recerca Biomedica De Lleida. Fundació Dr. Pifarre
|
Neuroscience
|
Research Consortium
|
1.000.000
|
HR21-00824
|
A strategy to guide and promote spinal and visual axons regeneration after injury
|
Eloísa Herrera
|
Consejo Superior de Investigaciones Científicas (CSIC)
|
N/A
|
Neuroscience
|
Individual
|
495.500
|
HR21-01136
|
Deep learning of a hippocampal memory code in health and disease
|
Liset Menéndez de la Prida
|
Consejo Superior de Investigaciones Científicas (CSIC)
|
N/A
|
Neuroscience
|
Individual
|
491.700
|
HR21-01208
|
RBM10, a novel splicing regulator and tumor suppressor: from mechanisms to therapies
|
Juan Valcárcel
|
Centre de Regulació Genòmica (CRG)
|
Fundación del Sector Público Estatal Centro Nacional de Investigaciones Oncológicas Carlos III
|
Oncology
|
Research Consortium
|
816.239,46
|
HR21-00176
|
Understanding lncRNAs in replicative stress and colorectal cancer: from cancer biology to single-molecules
|
Maite Huarte
|
Fundación para la Investigación Médica Aplicada (FIMA/CIMA)
|
Consejo Superior de Investigaciones Científicas (CSIC) - Fundación del Sector Público Estatal Centro Nacional de Investigaciones Oncológicas Carlos III
|
Oncology
|
Research Consortium
|
995.200
|
HR21-00761
|
IL7R in lung cancer development, metastasis and resistance to immune checkpoint inhibitor therapy
|
João Barata
|
Instituto de Medicina Molecular
|
Fundación para la Investigación Biomédica del Hospital Universitario 12 de Octubre - Fundación del Sector Público Estatal Centro Nacional de Investigaciones Oncológicas Carlos III
|
Oncology
|
HR Consortium
|
999.962
|
HR21-00083
|
Interleukin-8 and neutrophil extracelular traps as actionable hurdles for cancer immunotherapy
|
Ignacio Melero
|
Fundación para la Investigación Médica Aplicada (FIMA/CIMA)
|
N/A
|
Oncology
|
Individual
|
498.850
|
HR21-00020
|
Cracking the cancer tubulin code for precision oncology
|
Helder Maiato
|
i3S – Instituto de Investigação e Inovação em Saúde da Universidade do Porto - Associação
|
N/A
|
Oncology
|
Individual
|
499.983
|
Proyectos galardonados en colaboración con la Fundación Luzón |
HR21-00931
|
Targeting TDP-43 with protein kinase inhibitors: a effective and measurable therapy for ALS
|
Ana Martinez
|
Consejo Superior de Investigaciones Científicas (CSIC)
|
FARM-ID - Associação da Faculdade de Farmácia para a Investigação e Desenvolvimento -Universidad Complutense de Madrid
|
Neuroscience
|
Research Consortium
|
500.000
|
Proyectos galardonados en colaboración con la Fundação para a Ciência e a Tecnologia, I.P. en el marco de la “Iniciativa Ibérica de Investigaçao e Inovaçao Biomédica, i4b" |
HR21-01212
|
Decoding the non-code of beta-cells cis-regulation
|
Jose Bessa
|
i3S – Instituto de Investigação e Inovação em Saúde da Universidade do Porto - Associação
|
N/A
|
Cardiovascular and associated metabolic diseases
|
Individual
|
499.355
|
HR21-00605
|
Protecting the brain from metastatic breast cancer
|
Miguel Castanho
|
Instituto de Medicina Molecular
|
Asociación Instituto Biodonostia - FARM-ID - Associação da Faculdade de Farmácia para a Investigação e Desenvolvimento - Asociación Centro de Investigación Cooperativa en Biomateriales
|
Enabling Technologies
|
Research Consortium
|
632.841
|
HR21-00533
|
A flexible platform for generating synthetic virus to control infectious diseases
|
Joana Azeredo
|
Universidade do Minho
|
N/A
|
Infectious diseases
|
Individual
|
492.460,48
|
HR21-01077
|
Regulation of prefrontal cortical synaptic function and behavior by chronic stress-induced microRNA-186-5p
|
Paulo Pinheiro
|
Centro de Neurociências e Biologia Celular
|
N/A
|
Neuroscience
|
Individual
|
492.304,48
|
HR21-00077
|
Regulatory RNA–protein interactions at telomeres in healthy cells and during malignant transformation
|
Claus Maria Azzalin
|
Instituto de Medicina Molecular
|
N/A
|
Oncology
|
Individual
|
495.792
|